Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery

Launched by ASWAN UNIVERSITY HOSPITAL · Oct 13, 2018

Keywords

ClinConnect Summary

All women admitted to the reception unit for vaginal delivery were invited to participate in the study. The investigators included women aged (20-35 years) with a singleton pregnancy in a cephalic presentation between 38 and 42 weeks gestation. The participated women have entered the screening phase of the study. This phase included history taking (age, parity, and gestational age) with measurement of weight, temperature, and initial hemoglobin level. The investigators excluded women with medical disorders such as cardiac, hepatic, renal, neurologic disorders thromboembolic disease, blood d...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • All women admitted to the reception unit for vaginal delivery
• • women aged (20-35 years) with a singleton pregnancy in a cephalic presentation between 38 and 42 weeks gestation.
• Exclusion Criteria:
• • medical disorders such as cardiac, hepatic, renal, neurologic disorders thromboembolic disease, blood disorders, diabetes, gestational hypertension, and pre-eclampsia.
• • -Women at risk for PPH as grand multipara (parity \>5), multiple pregnancies, polyhydramnios, fetal macrosomia, antepartum hemorrhage, prolonged, and obstructed labor were also excluded.-
• • Moreover, we excluded women with a scarred uterus or previous instrumental delivery and those suffering from hypersensitivity to TA.